A phase II prospective study of gemcitabine and platin-based combination as first-line chemotherapy for metastatic Bellini duct carcinoma patients. Results of GETUG study

Stéphane Culine, F. Rolland, Brigitte Duclos et al.|Journal of Clinical Oncology|2005

Cited by 3